Eli Lilly & Co.

LLY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009 FY2008 FY2007 FY2006
Assets
Cash & Equivalents $4.46B $5.50B $3.22B $3.11B
Accounts Receivable $3.34B $2.78B
Inventory $2.85B $2.49B
Total Current Assets $12.49B $12.45B
Property, Plant & Equipment $8.20B $8.63B
Goodwill $1.18B
Intangible Assets (Excl. Goodwill)
Total Assets $27.46B $29.21B
Liabilities
Accounts Payable $968.1M $885.8M
Total Current Liabilities $6.57B $13.11B
Long-Term Debt $6.63B $4.62B
Total Liabilities $17.94B $22.47B
Stockholders' Equity
Retained Earnings $9.83B $7.65B
Total Stockholders' Equity $9.53B $6.74B
← Newer Page 3 of 3 Older →